➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Moodys
Mallinckrodt
Merck
Colorcon
McKesson
Express Scripts

Last Updated: September 23, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR BUDESONIDE; FORMOTEROL FUMARATE DIHYDRATE

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

All Clinical Trials for Budesonide; Formoterol Fumarate Dihydrate

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00569712 ↗ Studying Genes in Blood and Lung Fluid Samples From Patients With Chronic Obstructive Pulmonary Disease With or Without a Previous Diagnosis of Lung Cancer or With Asthma Treated With Budesonide and Formoterol Completed Astra Zeneca Canada Phase 1 2007-01-01 RATIONALE: Studying the genes expressed in samples of blood and lung fluid in the laboratory from patients receiving budesonide and formoterol may help doctors learn more about the effect of budesonide and formoterol on gene expression and biomarkers. PURPOSE: This clinical trial is studying genes in blood and lung fluid samples from patients with chronic obstructive pulmonary disease, with or without a previous diagnosis of lung cancer, or with asthma treated with budesonide and formoterol.
NCT00569712 ↗ Studying Genes in Blood and Lung Fluid Samples From Patients With Chronic Obstructive Pulmonary Disease With or Without a Previous Diagnosis of Lung Cancer or With Asthma Treated With Budesonide and Formoterol Completed British Columbia Cancer Agency Phase 1 2007-01-01 RATIONALE: Studying the genes expressed in samples of blood and lung fluid in the laboratory from patients receiving budesonide and formoterol may help doctors learn more about the effect of budesonide and formoterol on gene expression and biomarkers. PURPOSE: This clinical trial is studying genes in blood and lung fluid samples from patients with chronic obstructive pulmonary disease, with or without a previous diagnosis of lung cancer, or with asthma treated with budesonide and formoterol.
NCT00964535 ↗ Bioequivalence Study of Budesonide/Formoterol Easyhaler and Symbicort Turbohaler in Asthmatics Completed Orion Corporation, Orion Pharma Phase 1/Phase 2 2009-09-01 The purpose of this study is to compare the test product Budesonide/formoterol Easyhaler with the marketed product Symbicort Turbohaler in terms of the drug absorbed into the bloodstream.
NCT01386996 ↗ Comparison of Budesonide and Formoterol Absorption From Budesonide/Formoterol Easyhaler and Symbicort Turbuhaler Completed Orion Corporation, Orion Pharma Phase 1 2011-07-01 The purpose of this study is to compare the test product Budesonide/formoterol Easyhaler with the marketed product Symbicort Turbuhaler in terms of the drug absorbed into the bloodstream.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Budesonide; Formoterol Fumarate Dihydrate

Condition Name

Condition Name for Budesonide; Formoterol Fumarate Dihydrate
Intervention Trials
Asthma 8
Lung Cancer 1
COPD 1
Chronic Obstructive Pulmonary Disease (COPD) 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Budesonide; Formoterol Fumarate Dihydrate
Intervention Trials
Pulmonary Disease, Chronic Obstructive 3
Asthma 2
Lung Diseases, Obstructive 2
Lung Diseases 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Budesonide; Formoterol Fumarate Dihydrate

Trials by Country

Trials by Country for Budesonide; Formoterol Fumarate Dihydrate
Location Trials
United States 24
Finland 3
United Kingdom 2
Russian Federation 1
Sweden 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Budesonide; Formoterol Fumarate Dihydrate
Location Trials
Maine 1
Pennsylvania 1
Massachusetts 1
Minnesota 1
Missouri 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Budesonide; Formoterol Fumarate Dihydrate

Clinical Trial Phase

Clinical Trial Phase for Budesonide; Formoterol Fumarate Dihydrate
Clinical Trial Phase Trials
Phase 4 1
Phase 3 3
Phase 1/Phase 2 1
[disabled in preview] 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Budesonide; Formoterol Fumarate Dihydrate
Clinical Trial Phase Trials
Completed 7
Not yet recruiting 1
Recruiting 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Budesonide; Formoterol Fumarate Dihydrate

Sponsor Name

Sponsor Name for Budesonide; Formoterol Fumarate Dihydrate
Sponsor Trials
Orion Corporation, Orion Pharma 3
Intech Biopharm Ltd. 2
British Columbia Cancer Agency 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Budesonide; Formoterol Fumarate Dihydrate
Sponsor Trials
Industry 9
Other 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson
Medtronic
Dow
AstraZeneca
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.